Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
FibroGen lays off 75% of US staff as cancer drug flunks 2 more trials
Fierce Biotech
Wed, 07/31/24 - 10:22 am
FibroGen
layoffs
clinical trials
pancreatic cancer
Revolution's pan-RAS drug clears path to Phase III in pancreatic cancer
First Word Pharma
Mon, 07/15/24 - 11:24 pm
Revolution Medicines
RMC-6236
pancreatic cancer
Oncolytics doses first subject in pancreatic cancer trial
Clinical Trials Arena
Fri, 06/21/24 - 11:44 am
Oncolytics
clinical trials
mFolfirinox
metastatic pancreatic cancer
pancreatic cancer
ASCO: Early Purple data gain ground in metastatic pancreatic cancer
Fierce Biotech
Sun, 06/2/24 - 02:42 pm
ASCO 2024
Purple Biotech
pancreatic cancer
CM24
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena
Fri, 05/24/24 - 11:25 am
ASCO 2024
Verastem
avutometinib
pancreatic cancer
clinical trials
AIM ImmunoTech reports progress in pancreatic cancer drug trial
Clinical Trials Arena
Tue, 04/30/24 - 08:34 am
AIM ImmunoTech
clinical trials
Ampligen
Imfinzi
pancreatic cancer
Candel wins FDA orphan drug designation for pancreatic cancer drug
Clinical Trials Arena
Sun, 04/14/24 - 01:23 pm
FDA
Candel Therapeutics
CAN-2409
pancreatic cancer
orphan drugs
With FDA nod for Onivyde combo, Ipsen ends 10-year drought in newly diagnosed pancreatic cancer
Fierce Pharma
Tue, 02/13/24 - 11:12 pm
Ipsen
Onivyde
Nalirifox
pancreatic cancer
FDA
AIM gains approval for trial of Ampligen for pancreatic cancer
Clinical Trials Arena
Thu, 01/25/24 - 09:04 pm
AIM ImmunoTech
clinical trials
Europe
Ampligen
pancreatic cancer
Mushroom-derived drug posts improved survival data in Golden Biotech’s pancreatic cancer trial
Fierce Biotech
Thu, 01/18/24 - 11:21 am
Golden Biotechnology Corporation
clinical trials
pancreatic cancer
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409
Yahoo/Zacks.com
Thu, 12/14/23 - 09:36 am
Candel Therapeutics
FDA
fast track
CAN-2409
pancreatic cancer
5 Cancer Vaccines to Watch in 2024
BioSpace
Mon, 11/20/23 - 10:15 am
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
Biopharma Reporter
Tue, 10/3/23 - 10:20 am
BPGbio
artificial intelligence
pancreatic cancer
BPM 31510
clinical trials
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
BioSpace
Tue, 09/26/23 - 10:13 pm
Cardiff Oncology
pancreatic cancer
Onvansertib
clinical trials
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer
BioSpace
Mon, 08/28/23 - 11:39 am
Novartis
Xoma
NIS793
pancreatic cancer
Novartis axes secretive obesity program after high-risk, high-reward bet fails
Fierce Biotech
Tue, 07/18/23 - 11:41 am
Novartis
obesity
pancreatic cancer
Galera earns key FDA designation for pancreatic cancer drug
Clinical Trials Arena
Fri, 05/19/23 - 11:29 am
Galera Therapeutics
pancreatic cancer
FDA
rucosopasem
orphan drugs
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
Thu, 02/23/23 - 10:00 am
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
Pages
1
2
3
4
5
6
7
8
9
next ›
last »